LUCI DAVID P 4
4 · Acurx Pharmaceuticals, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option
2023-02-13+130,000→ 130,000 totalExercise: $3.41Exp: 2033-02-12→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]On February 13, 2023 (the " Grant Date"), the Reporting Person was granted stock options to purchase 130,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.